Loading
Latest filing published 11 Feb 2016 for Ocata Therapeutics, Inc.. Read the official filing
No signal scores available.
Robert Lanza has a single filing on record, published on 11 February 2016: a transaction in Ocata Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration